Actuate Therapeutics, Inc. Common stock (ACTU)
Healthcare
Biotechnology
1.10 $
-5.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Actuate Therapeutics, Inc. Common stock (ACTU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -18 | -22 | -22 | -19 | |
| 0.7 | 0.4 | 2.0 | 6.0 | |
| 1.7 | 2.6 | 1.1 | -3.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | 0.5 | – | |
| – | 0.0 | 5.5 | 0.0 | |
| 19 | 4.1 | 28 | 24 | |
| 1.5 | -17 | 5.7 | 4.5 | |
| -18 | -22 | -22 | -19 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.